This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
rsi: Archive
Down -13.03% in 4 Weeks, Here's Why Chegg (CHGG) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Chegg (CHGG) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
CHGGPositive Net Change
rsi stock-price-movement
After Plunging -11.74% in 4 Weeks, Here's Why the Trend Might Reverse for Veeva (VEEV)
by Zacks Equity Research
Veeva (VEEV) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
VEEVNegative Net Change
rsi stock-price-movement
Down -7.15% in 4 Weeks, Here's Why You Should You Buy the Dip in Franklin Resources (BEN)
by Zacks Equity Research
Franklin Resources (BEN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
BENNegative Net Change
rsi stock-price-movement
Here's Why Planet Labs PBC (PL) is Poised for a Turnaround After Losing -18.1% in 4 Weeks
by Zacks Equity Research
Planet Labs PBC (PL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
PLPositive Net Change
rsi stock-price-movement
Down -8.7% in 4 Weeks, Here's Why Performance Food (PFGC) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Performance Food (PFGC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
PFGCNegative Net Change
rsi stock-price-movement
After Plunging -5.45% in 4 Weeks, Here's Why the Trend Might Reverse for IBM (IBM)
by Zacks Equity Research
IBM (IBM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
IBMNegative Net Change
rsi stock-price-movement
DiaMedica Therapeutics (DMAC) Loses -19.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
DiaMedica Therapeutics (DMAC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
DMACNegative Net Change
rsi stock-price-movement
Tanger (SKT) Loses -5.51% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Tanger (SKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
SKTNegative Net Change
rsi stock-price-movement
Down -8.91% in 4 Weeks, Here's Why You Should You Buy the Dip in North American Construction (NOA)
by Zacks Equity Research
North American Construction (NOA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
NOANegative Net Change
rsi stock-price-movement
Down -41.74% in 4 Weeks, Here's Why Danimer Scientific (DNMR) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Danimer Scientific (DNMR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
rsi stock-price-movement
After Plunging -31.35% in 4 Weeks, Here's Why the Trend Might Reverse for Phunware (PHUN)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Phunware (PHUN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
PHUNNegative Net Change
rsi stock-price-movement
MEREO BIOPHARMA (MREO) Loses -12.74% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for MEREO BIOPHARMA (MREO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
MREOPositive Net Change
rsi stock-price-movement
After Plunging -6.27% in 4 Weeks, Here's Why the Trend Might Reverse for Equity Lifestyle Properties (ELS)
by Zacks Equity Research
Equity Lifestyle Properties (ELS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ELSNegative Net Change
rsi stock-price-movement
Fastenal (FAST) Loses -7.16% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Fastenal (FAST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
FASTNegative Net Change
rsi stock-price-movement
Down -14.68% in 4 Weeks, Here's Why Angi (ANGI) Looks Ripe for a Turnaround
by Zacks Equity Research
Angi (ANGI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ANGINegative Net Change
rsi stock-price-movement
After Plunging -14.25% in 4 Weeks, Here's Why the Trend Might Reverse for SMART Global (SGH)
by Zacks Equity Research
SMART Global (SGH) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
SGHPositive Net Change
rsi stock-price-movement
Here's Why Zscaler (ZS) is Poised for a Turnaround After Losing -8.68% in 4 Weeks
by Zacks Equity Research
Zscaler (ZS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ZSNegative Net Change
rsi stock-price-movement
Down -7.36% in 4 Weeks, Here's Why You Should You Buy the Dip in Rayonier (RYN)
by Zacks Equity Research
Rayonier (RYN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
RYNNegative Net Change
rsi stock-price-movement
Cytek Biosciences (CTKB) Loses -7.27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Cytek Biosciences (CTKB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
CTKBPositive Net Change
rsi stock-price-movement
Down -13.93% in 4 Weeks, Here's Why Consolidated Water (CWCO) Looks Ripe for a Turnaround
by Zacks Equity Research
Consolidated Water (CWCO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
CWCONegative Net Change
rsi stock-price-movement
Down -18.89% in 4 Weeks, Here's Why Angi (ANGI) Looks Ripe for a Turnaround
by Zacks Equity Research
Angi (ANGI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ANGINegative Net Change
rsi stock-price-movement
Groupon (GRPN) Loses -39.45% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Groupon (GRPN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
GRPNNegative Net Change
rsi stock-price-movement
Down -25.88% in 4 Weeks, Here's Why You Should You Buy the Dip in Gain Therapeutics (GANX)
by Zacks Equity Research
Gain Therapeutics (GANX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
GANXNegative Net Change
rsi stock-price-movement
Zymeworks (ZYME) Loses -13.41% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Zymeworks (ZYME) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ZYMENegative Net Change
rsi stock-price-movement
Sunoco LP (SUN) Loses -9.91% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Sunoco LP (SUN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
SUNPositive Net Change
rsi stock-price-movement